Thomas Wolfel
Inventor
Stats
- 14 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 14 US Patents Issued
- 15 US Applications Filed
- 123 Total Citation Count
- Aug 31, 2006 Most Recent Filing
- Jun 23, 1993 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Ludwig Institute | 1
| 1998
|
| JOHANNES GUTENBERG-UNIVERSITAT MAINZ | 1
| 2006
|
| LUDWIG INSTITUTE FOR CANCER RESEARCH | 1
2 4 3 1 1 1 | 1993
1994 1995 1996 1998 1999 2001 |
Inventor Addresses
| Address | Duration |
|---|---|
| Mainz, BE | Jan 30, 96 - Apr 28, 98 |
| Mainz, DE | May 21, 96 - Apr 23, 09 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 7 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2009/0104,186 | 2009 | Melanoma-associated MHC class I associated oligopeptides and the uses thereof | 6 |
| 6669946 | 2003 | METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HUMAN LEUKOCYTE ANTIGEN TYROSINASE DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS | 1 |
| 6284476 | 2001 | Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals | 0 |
| 6201111 | 2001 | Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors | 11 |
| 6001975 | 1999 | Precursor processed to at least one tumor rejection antigen presented by HLA-A2 | 11 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.